182 related articles for article (PubMed ID: 32463597)
1. High expression of KITLG is a new hallmark activating the MAPK pathway in type A and AB thymoma.
Yang Z; Liu S; Wang Y; Chen Y; Zhang P; Liu Y; Zhang H; Zhang P; Tao Z; Xiong K
Thorac Cancer; 2020 Jul; 11(7):1944-1954. PubMed ID: 32463597
[TBL] [Abstract][Full Text] [Related]
2. Thymoma Associated Myasthenia Gravis (TAMG): Differential Expression of Functional Pathways in Relation to MG Status in Different Thymoma Histotypes.
Yamada Y; Weis CA; Thelen J; Sticht C; Schalke B; Ströbel P; Marx A
Front Immunol; 2020; 11():664. PubMed ID: 32373124
[TBL] [Abstract][Full Text] [Related]
3. Molecular pathology of thymomas: implications for diagnosis and therapy.
Marx A; Belharazem D; Lee DH; Popovic ZV; Reißfelder C; Schalke B; Schölch S; Ströbel P; Weis CA; Yamada Y
Virchows Arch; 2021 Jan; 478(1):101-110. PubMed ID: 33674910
[TBL] [Abstract][Full Text] [Related]
4. Expression of
Masunaga A; Omatsu M; Kunimura T; Uematsu S; Kamio Y; Kitami A; Miyagi Y; Hiroshima K; Suzuki T
J Clin Pathol; 2017 Aug; 70(8):690-696. PubMed ID: 28119349
[TBL] [Abstract][Full Text] [Related]
5. Activation of the mTOR/ Akt pathway in thymic epithelial cells derived from thymomas.
Maury JM; Merveilleux du Vignaux C; Drevet G; Zarza V; Chalabreysse L; Maisse C; Gineys B; Dolmazon C; Tronc F; Girard N; Leroux C
PLoS One; 2019; 14(3):e0197655. PubMed ID: 30897085
[TBL] [Abstract][Full Text] [Related]
6. A novel prognostic signature of seven genes for the prediction in patients with thymoma.
Li Q; Su YL; Shen WX
J Cancer Res Clin Oncol; 2019 Jan; 145(1):109-116. PubMed ID: 30328513
[TBL] [Abstract][Full Text] [Related]
7. Identification of Molecular Characteristics and New Prognostic Targets for Thymoma by Multiomics Analysis.
Liu D; Zhang P; Zhao J; Yang L; Wang W
Biomed Res Int; 2021; 2021():5587441. PubMed ID: 34104648
[TBL] [Abstract][Full Text] [Related]
8. Membrane-to-nucleus signaling links insulin-like growth factor-1- and stem cell factor-activated pathways.
Hayashi Y; Asuzu DT; Gibbons SJ; Aarsvold KH; Bardsley MR; Lomberk GA; Mathison AJ; Kendrick ML; Shen KR; Taguchi T; Gupta A; Rubin BP; Fletcher JA; Farrugia G; Urrutia RA; Ordog T
PLoS One; 2013; 8(10):e76822. PubMed ID: 24116170
[TBL] [Abstract][Full Text] [Related]
9. Identification of prognostic and subtype-specific potential miRNAs in thymoma.
Wei J; Liu Z; Wu K; Yang D; He Y; Chen GG; Zhang J; Lin J
Epigenomics; 2017 May; 9(5):647-657. PubMed ID: 28517980
[TBL] [Abstract][Full Text] [Related]
10. p16INK4, pRB, p53 and cyclin D1 expression and hypermethylation of CDKN2 gene in thymoma and thymic carcinoma.
Hirabayashi H; Fujii Y; Sakaguchi M; Tanaka H; Yoon HE; Komoto Y; Inoue M; Miyoshi S; Matsuda H
Int J Cancer; 1997 Nov; 73(5):639-44. PubMed ID: 9398039
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation of GHSR, GNG4, HOXD9 and SALL3 is a common epigenetic alteration in thymic carcinoma.
Kishibuchi R; Kondo K; Soejima S; Tsuboi M; Kajiura K; Kawakami Y; Kawakita N; Sawada T; Toba H; Yoshida M; Takizawa H; Tangoku A
Int J Oncol; 2020 Jan; 56(1):315-326. PubMed ID: 31746370
[TBL] [Abstract][Full Text] [Related]
12. Expression patterns for Bcl-2, EMA, β-catenin, E-cadherin, PAX8, and MIB1 in thymomas.
Suster D; Miller JA; Pihan G; Mackinnon AC; Suster S
Mod Pathol; 2021 Oct; 34(10):1831-1838. PubMed ID: 34135467
[TBL] [Abstract][Full Text] [Related]
13. Genome‑wide DNA methylation profile of thymomas and potential epigenetic regulation of thymoma subtypes.
Bi Y; Meng Y; Niu Y; Li S; Liu H; He J; Zhang Y; Liang N; Liu L; Mao X; Yan J; Long B; Liang Z; Wu Z
Oncol Rep; 2019 May; 41(5):2762-2774. PubMed ID: 30816514
[TBL] [Abstract][Full Text] [Related]
14. Type AB thymoma is not a mixed tumor of type A and type B thymomas, but a distinct type of thymoma.
Miki Y; Hamada K; Yoshino T; Miyatani K; Takahashi K
Virchows Arch; 2014 Jun; 464(6):725-34. PubMed ID: 24802113
[TBL] [Abstract][Full Text] [Related]
15. Identification and Characterization of Non-Coding RNAs in Thymoma.
Ji G; Ren R; Fang X
Med Sci Monit; 2021 Jul; 27():e929727. PubMed ID: 34219124
[TBL] [Abstract][Full Text] [Related]
16. Glia maturation factor-beta is produced by thymoma and may promote intratumoral T-cell differentiation.
Yamazaki H; Tateyama H; Asai K; Fukai I; Fujii Y; Tada T; Eimoto T
Histopathology; 2005 Sep; 47(3):292-302. PubMed ID: 16115230
[TBL] [Abstract][Full Text] [Related]
17. A large microRNA cluster on chromosome 19 is a transcriptional hallmark of WHO type A and AB thymomas.
Radovich M; Solzak JP; Hancock BA; Conces ML; Atale R; Porter RF; Zhu J; Glasscock J; Kesler KA; Badve SS; Schneider BP; Loehrer PJ
Br J Cancer; 2016 Feb; 114(4):477-84. PubMed ID: 26766736
[TBL] [Abstract][Full Text] [Related]
18. Mutational status of EGFR and KIT in thymoma and thymic carcinoma.
Yoh K; Nishiwaki Y; Ishii G; Goto K; Kubota K; Ohmatsu H; Niho S; Nagai K; Saijo N
Lung Cancer; 2008 Dec; 62(3):316-20. PubMed ID: 18448188
[TBL] [Abstract][Full Text] [Related]
19. Mutational status of the epidermal growth factor receptor (EGFR) gene in thymomas and thymic carcinomas.
Meister M; Schirmacher P; Dienemann H; Mechtersheimer G; Schnabel PA; Kern MA; Herpel E; Xu EC; Muley T; Thomas M; Rieker RJ
Cancer Lett; 2007 Apr; 248(2):186-91. PubMed ID: 16919868
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic Features of Thymoma With the Expression of Programmed Death Ligand 1.
Hakiri S; Fukui T; Mori S; Kawaguchi K; Nakamura S; Ozeki N; Kato T; Goto M; Yatabe Y; Yokoi K
Ann Thorac Surg; 2019 Feb; 107(2):418-424. PubMed ID: 30312607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
